TNGX - Tango Therapeutics GAAP EPS of -$0.23 revenue of $10.7M November, 08 2023 08:44 AM Tango Therapeutics Inc. 2023-11-08 08:44:56 ET Tango Therapeutics press release ( NASDAQ: TNGX ): Q3 GAAP EPS of -$0.23. Revenue of $10.7M. For further details see: Tango Therapeutics GAAP EPS of -$0.23, revenue of $10.7M